111 Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$895K Sell
1,785
-280
-14% -$134K 0.15% 143
2026
Q1
$1.02M Buy
2,065
+916
+80% +$497K 0.25% 79
2025
Q4
$666K Buy
+1,149
New +$650K 0.15% 123
2025
Q3
Sell
-8,261
Closed -$3.35M 686
2025
Q2
$3.35M Buy
8,261
+4,958
+150% +$2.07M 0.58% 32
2025
Q1
$1.64M Buy
3,303
+2,172
+192% +$1.18M 0.32% 64
2024
Q4
$588K Buy
+1,131
New +$622K 0.12% 176

Other funds holding TMO

111 Capital's TMO Position: Q2 2026 in Review

111 Capital reduced its Thermo Fisher Scientific (TMO) stake by 14% in Q2 2026, selling an estimated $134K and leaving 1,785 shares worth $895K. The position accounts for 0.15% of the portfolio, ranked #143.

111 Capital first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.35M in Q2 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • 111 Capital held 1,785 shares of Thermo Fisher Scientific worth $895K as of Q2 2026.
  • 111 Capital sold 280 Thermo Fisher Scientific shares in Q2 2026, an estimated $134K.
  • Thermo Fisher Scientific made up 0.15% of 111 Capital's portfolio in Q2 2026, its #143 holding.
  • 111 Capital first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
  • 111 Capital's Thermo Fisher Scientific position peaked at $3.35M in Q2 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.